Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut 2020-08, Vol.69 (8), p.1545-1547
Hauptverfasser:	Targher, Giovanni, Mantovani, Alessandro, Byrne, Christopher D, Wang, Xiao-Bo, Yan, Hua-Dong, Sun, Qing-Feng, Pan, Ke-Hua, Zheng, Kenneth I, Chen, Yong-Ping, Eslam, Mohammed, George, Jacob, Zheng, Ming-Hua
Format:	Artikel
Sprache:	eng
Schlagworte:	Alanine Alanine transaminase Aspartate aminotransferase Betacoronavirus Bilirubin Biochemical characteristics Blood pressure Body mass index C-reactive protein Cell number Cholesterol Coronavirus Infections Coronaviruses COVID-19 Diabetes Diabetes mellitus Endocrinology Fatty liver Fibrosis Gastroenterology & Hepatology Hemoglobin Hepatitis High density lipoprotein Hospitals Humans Illnesses Laboratories Life Sciences & Biomedicine Lipoproteins Liver Liver diseases Low density lipoprotein Lung diseases Lymphocytes Metabolism Non-alcoholic Fatty Liver Disease Obesity Pandemics Patients Pneumonia, Viral Procalcitonin Prothrombin Retrospective Studies SARS-CoV-2 Science & Technology Thromboplastin Triglycerides Variables γ-Glutamyltransferase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!